Skip to main content
. 2017 Mar 4;57(1):37–43. doi: 10.3233/JAD-161168

Fig.1.

Fig.1

A) Baseline pBDNF was significantly higher in patients with moderate AD (CDR 2) than in healthy subjects (HE). B) In healthy subjects, a better cognitive status (higher MMSE score) was associated to a higher pBDNF. C) In AD patients, more impaired cognition (higher ADAS-Cogscore) was associated to higher pBDNF. In A, columns and error bars represent back-transformed means and 95% confidence interval. In B and C, a constant was added to the log-transformed data to avoid showing negative values.